Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
Quetel L, Meiller C, Assié JB, Blum Y, Imbeaud S, Montagne F, Tranchant R, de Wolf J, Caruso S, Copin MC, Hofman V, Gibault L, Badoual C, Pintilie E, Hofman P, Monnet I, Scherpereel A, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D. Quetel L, et al. Among authors: jean d. Mol Oncol. 2020 Jun;14(6):1207-1223. doi: 10.1002/1878-0261.12651. Epub 2020 Mar 10. Mol Oncol. 2020. PMID: 32083805 Free PMC article.
Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma.
Sun S, Qi W, Rehrauer H, Ronner M, Hariharan A, Wipplinger M, Meiller C, Stahel R, Früh M, Cerciello F, Fonteneau JF, Jean D, Felley-Bosco E. Sun S, et al. Among authors: jean d. JTO Clin Res Rep. 2022 Nov 7;3(12):100430. doi: 10.1016/j.jtocrr.2022.100430. eCollection 2022 Dec. JTO Clin Res Rep. 2022. PMID: 36467966 Free PMC article.
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications.
Blum Y, Meiller C, Quetel L, Elarouci N, Ayadi M, Tashtanbaeva D, Armenoult L, Montagne F, Tranchant R, Renier A, de Koning L, Copin MC, Hofman P, Hofman V, Porte H, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, de Reyniès A, Jean D. Blum Y, et al. Among authors: jean d. Nat Commun. 2019 Mar 22;10(1):1333. doi: 10.1038/s41467-019-09307-6. Nat Commun. 2019. PMID: 30902996 Free PMC article.
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T, d'Almeida SM, Briolay T, Tabiasco J, Meiller C, Chéné AL, Cellerin L, Deshayes S, Delneste Y, Fonteneau JF, Boisgerault N, Bennouna J, Grégoire M, Jean D, Blanquart C. Blondy T, et al. Among authors: jean d, d almeida sm. J Immunother Cancer. 2020 Jun;8(1):e000182. doi: 10.1136/jitc-2019-000182. J Immunother Cancer. 2020. PMID: 32581053 Free PMC article.
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma.
Jean D, Delaunay T, Meiller C, Boisgerault N, Grard M, Caruso S, Blanquart C, Felley-Bosco E, Bennouna J, Tangy F, Grégoire M, Fonteneau JF. Jean D, et al. J Thorac Oncol. 2020 Jul;15(7):e113-e116. doi: 10.1016/j.jtho.2020.04.011. J Thorac Oncol. 2020. PMID: 32593448 Free article. No abstract available.
KRAS signaling in malignant pleural mesothelioma.
Marazioti A, Krontira AC, Behrend SJ, Giotopoulou GA, Ntaliarda G, Blanquart C, Bayram H, Iliopoulou M, Vreka M, Trassl L, Pepe MAA, Hackl CM, Klotz LV, Weiss SAI, Koch I, Lindner M, Hatz RA, Behr J, Wagner DE, Papadaki H, Antimisiaris SG, Jean D, Deshayes S, Grégoire M, Kayalar Ö, Mortazavi D, Dilege Ş, Tanju S, Erus S, Yavuz Ö, Bulutay P, Fırat P, Psallidas I, Spella M, Giopanou I, Lilis I, Lamort AS, Stathopoulos GT. Marazioti A, et al. Among authors: jean d. EMBO Mol Med. 2022 Feb 7;14(2):e13631. doi: 10.15252/emmm.202013631. Epub 2021 Dec 13. EMBO Mol Med. 2022. PMID: 34898002 Free PMC article.
203 results